Skip to main content
logo
Mines D'Or Orbec Inc. (BLUE)
Jun 2, 2025 - BLUE was delisted (reason: acquired by Carlyle and SK Capital)
4.970
0.00 (0.00%)
Inactive · Last trade price on May 30, 2025

bluebird bio Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-1.76-1.8-1.01-2.44-2.95-2.88
Net Income
-1.58-1.68-0.76-2.27-2.32-3.01
Earnings Per Share
-0.03-0.03-0.02-0.07-0.11-0.22
EPS Growth
------

Revenue by Segment
Fiscal YearFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '22 Dec '21 Dec '20 Dec '19
Gene Therapies
29.072.742.85114.0644.67
Other
0.430.860.81--

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Cash (Debt)
0.320.61.120.041.633.09
Net Cash Growth
-35.89%-46.72%2831.76%-97.65%-47.12%679.63%
Net Cash Per Share
0.010.010.030.000.070.22
Cash & Investments
0.320.61.120.041.633.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-1.64-1.97-0.3-2.09-3.04-2.42
Capital Expenditures
0.02-----0.01
Free Cash Flow
-1.62-1.97-0.3-2.09-3.04-2.43
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Selected indicators aren't available for this stock.